Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2011-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2010.09.012PMID 21050672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Genetic variation in normal tissue toxicity induced by ionizing radiation.

  2009cited by this paper
• Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype

  2009cited by this paper
• Genetic variants and normal tissue toxicity after radiotherapy: a systematic review.

  2009cited by this paper
• Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer.

  2008cited by this paper
• Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.

  2007cited by this paper
• TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors.

  2006cited by this paper
• Concurrent Chemoradiotherapy for Cervical Cancer: A Review of Large Randomized Trials and Perspectives for Asian Countries.

  2006cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004.

  2005cited by this paper
• Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.

  2005cited by this paper
• Long‐term results of high‐dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Microsatellite Polymorphisms in DNA Repair Genes XRCC1, XRCC3 and XRCC5 in Patients with Gynecological Tumors: Association with Late Clinical Radiosensitivity and Cancer Incidence

  2005cited by this paper
• The role of haplotypes in candidate gene studies

  2004cited by this paper
• Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

  2004cited by this paper
• E2F target genes: unraveling the biology.

  2004cited by this paper
• Genetic biomarkers of therapeutic radiation sensitivity.

  2004cited by this paper
• Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach.

  2004cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells.

  2003cited by this paper
• GENECOUNTING: haplotype analysis with missing genotypes

  2002cited by this paper
• Suppression of the STK15 oncogenic activity requires a transactivation‐independent p53 function

  2002cited by this paper
• Score tests for association between traits and haplotypes when linkage phase is ambiguous.

  2002cited by this paper
• Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

  2001cited by this paper
• Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

  2000cited by this paper
• NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.

  2000cited by this paper
• GOLD-Graphical Overview of Linkage Disequilibrium

  2000cited by this paper
• Gene Ontology: tool for the unification of biology

  2000cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

  1998cited by this paper
• CAND3: A ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 1lq23.1

  1997cited by this paper
• CAND3: a ubiquitously expressed gene immediately adjacent and in opposite transcriptional orientation to the ATM gene at 11q23.1.

  1997cited by this paper
• A gene transcribed from the bidirectional ATM promoter coding for a serine rich protein: amino acid sequence, structure and expression studies.

  1996cited by this paper
• Identification and characterization of a new gene physically linked to the ATM gene.

  1996cited by this paper
• DNA Binding Specificities and Pairing Rules of the Ah Receptor, ARNT, and SIM Proteins (*)

  1995cited by this paper

• CRM1 inhibits NPAT condensation and histone locus body formation via a competitive occupation strategy.

  2026cites this paper
• KPNA3 regulates histone locus body formation by modulating condensation and nuclear import of NPAT

  2024cites this paper
• The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect

  2023cites this paper
• Genetic variations in ATM and H2AX loci contribute to risk of hematological abnormalities in individuals exposed to BTEX chemicals

  2022cites this paper
• Characteristics of BRCA2 Mutated Prostate Cancer at Presentation

  2022cites this paper
• Significant Association Between XRCC1 Expression and Its rs25487 Polymorphism and Radiotherapy-Related Cancer Prognosis

  2021cites this paper
• The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics

  2021cites this paper
• Identification of New Tumor-Related Gene Mutations in Chinese Gastrointestinal Stromal Tumors

  2021cites this paper
• Individual response of humans to ionising radiation: governing factors and importance for radiological protection

  2020cites this paper
• A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)

  2019cites this paper
• Predictive value of single nucleotide polymorphisms in XRCC1 for radiation-induced normal tissue toxicity

  2018cites this paper
• Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach.

  2017cites this paper
• Genetic Variants in CD44 and MAT1A Confer Susceptibility to Acute Skin Reaction in Breast Cancer Patients Undergoing Radiation Therapy.

  2017cites this paper
• Meta-analysis of associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and adverse effects of cancer radiotherapy.

  2015cites this paper
• Screening for characteristic microRNAs between pre-invasive and invasive stages of cervical cancer

  2015cites this paper
• Polymorphisms in Radio-Responsive Genes and Its Association with Acute Toxicity among Head and Neck Cancer Patients

  2014cites this paper
• Prediction of normal tissue toxicity as part of the individualized treatment with radiotherapy in oncology patients.

  2012cites this paper
• Molecular predictive factors of outcome of radiotherapy in cervical cancer.

  2011cites this paper
• Genetics and genomics of radiotherapy toxicity: towards prediction

  2011cites this paper
• Radiation Response of the Normal Lung Tissue and Lung Tumors

  2011cites this paper